About this episode

The episode discusses the importance of integration site analysis in gene therapy safety evaluations with insights from experts at ProtaGene.

Integration site analysis is becoming a critical tool in evaluating the safety of gene therapies, but how does it actually work, and when does it matter most? Michael Stump and Matteo Franco of ProtaGene break down the science, the risk, and the evolving role of CROs in this rapidly changing field.

People in this episode

Hosts: Jordan Ruggieri, Lisa Crawford

Guests: Michael Stump, Matteo Franco

Topics covered

• genotoxicity
• gene therapies
• integration site analysis
• CROs
• safety evaluation

Keywords

• genotoxicity
• gene therapy
• integration site analysis
• CROs
• safety

Mentioned in this episode

Organizations: ProtaGene

More episodes of Absolute Gene-ius

• qPCR, nested PCR, and the search for bacterial serotypes · July 15, 2026 · 33 min
• How PCR, CRISPR, and animal models are advancing oncology research · July 1, 2026 · 16 min

Explore listener stats, chart rankings, contacts and more on the Absolute Gene-ius podcast page.